About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘japan retractions’ Category

Déjà vu: Double pub in the same issue earns a retraction

with 9 comments

biomedchromAlways do a careful reading of your galleys, editors.

We imagine readers of Biomedical Chromatography’s special issue, “Reminiscences of Chang Kee Lim,” did some flipping back and forth when they found the same paper published twice.

Here’s the resulting notice for “Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole”:  Read the rest of this entry »

About these ads

Written by Cat Ferguson

August 28, 2014 at 11:30 am

Researcher with 25 retractions covered up other fraud, says university

with 14 comments

Shigeaki Kato

Shigeaki Kato

The Japanese endocrinology researcher Shigeaki Kato, with at least 25 retractions to his name, is alleged to have been the ringleader of a scheme to cover up other research misconduct at the University of Tokyo, his former employer, which investigated the activity.

According to the Japan Times, Kato and three other colleagues took steps to hide evidence of image manipulation in five of 51 theses between 1996 and 2011: Read the rest of this entry »

Written by amarcus41

August 6, 2014 at 11:00 am

STAP stem cell co-author commits suicide: Reports

with 32 comments

Yoshiki Sasai, via RIKEN

Yoshiki Sasai, via RIKEN

In a stunning and tragic development, a co-author of the now-retracted Nature papers claiming to have found an easy way to create stem cells has committed suicide, according to news reports in Japan.

According to the Japan Times, RIKEN deputy director Yoshiki Sasai has died: Read the rest of this entry »

Written by Ivan Oransky

August 4, 2014 at 11:10 pm

UT-Southwestern cancer research group notches ninth retraction

with one comment

lung cancerA research team at the University of Texas-Southwestern that has retracted eight papers for image manipulation has retracted another, this one in Lung Cancer.

Here’s the notice for “Aberrant methylation of Reprimo in lung cancer,” published by Adi Gazdar’s group: Read the rest of this entry »

Paper about widely touted but unapproved “cure” for cancer, autism retracted

with 11 comments

int j cancerA paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.

Here’s the notice from the International Journal of Cancer about a 2007 paper purporting to show that the substance, GcMAF, is useful against breast cancer: Read the rest of this entry »

Publishing gadfly demands journal editor’s resignation, then has “fairly incomprehensible” paper rejected

with 60 comments

sci eng ethicsA scientific publishing gadfly who was banned earlier this year from an Elsevier journal for “personal attacks and threats” has had a paper rejected by a Springer journal after he called for the editor’s resignation because of alleged incompetence.

As detailed in a comment left at Retraction Watch, Jaime A. Teixeira da Silva submitted a manuscript titled “One Conjunction, a World of Ethical Difference: How Elsevier, the ICMJE and Neurology Define Authorship” to Science and Engineering Ethics on November 11, 2012. As of last week, despite a number of messages sent to editors of the journal, he had not had a decision on the manuscript.

As a result, on July 14 of this year, Teixeira da Silva sent this letter to journal editor Raymond Spier and to Stephanie Bird, an editorial board member assigned to the manuscript: Read the rest of this entry »

Written by Ivan Oransky

July 21, 2014 at 3:55 pm

STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems

with 12 comments

nature 714A significant chapter of the nearly six-month saga of the STAP stem cell controversy has come to an end, with Nature running retraction notices for the two papers involved. The journal has also published an editorial about the case that’s worth a read.

The retractions for “Bidirectional developmental potential in reprogrammed cells with acquired pluripotency” and “Stimulus-triggered fate conversion of somatic cells into pluripotency” both read: Read the rest of this entry »

Written by Ivan Oransky

July 2, 2014 at 8:37 am

Follow

Get every new post delivered to your Inbox.

Join 34,472 other followers